1. Home
  2. NRXP vs TRSG Comparison

NRXP vs TRSG Comparison

Compare NRXP & TRSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • TRSG
  • Stock Information
  • Founded
  • NRXP 2015
  • TRSG 1996
  • Country
  • NRXP United States
  • TRSG Singapore
  • Employees
  • NRXP N/A
  • TRSG N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • TRSG
  • Sector
  • NRXP Health Care
  • TRSG
  • Exchange
  • NRXP Nasdaq
  • TRSG NYSE
  • Market Cap
  • NRXP 32.6M
  • TRSG 27.0M
  • IPO Year
  • NRXP N/A
  • TRSG 2024
  • Fundamental
  • Price
  • NRXP $2.94
  • TRSG $1.58
  • Analyst Decision
  • NRXP Strong Buy
  • TRSG
  • Analyst Count
  • NRXP 4
  • TRSG 0
  • Target Price
  • NRXP $28.50
  • TRSG N/A
  • AVG Volume (30 Days)
  • NRXP 189.6K
  • TRSG 4.2K
  • Earning Date
  • NRXP 08-13-2025
  • TRSG 05-14-2025
  • Dividend Yield
  • NRXP N/A
  • TRSG N/A
  • EPS Growth
  • NRXP N/A
  • TRSG N/A
  • EPS
  • NRXP N/A
  • TRSG N/A
  • Revenue
  • NRXP N/A
  • TRSG $12,810,249.00
  • Revenue This Year
  • NRXP N/A
  • TRSG N/A
  • Revenue Next Year
  • NRXP N/A
  • TRSG N/A
  • P/E Ratio
  • NRXP N/A
  • TRSG N/A
  • Revenue Growth
  • NRXP N/A
  • TRSG N/A
  • 52 Week Low
  • NRXP $1.10
  • TRSG $1.00
  • 52 Week High
  • NRXP $6.01
  • TRSG $4.57
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 40.46
  • TRSG N/A
  • Support Level
  • NRXP $3.12
  • TRSG N/A
  • Resistance Level
  • NRXP $3.53
  • TRSG N/A
  • Average True Range (ATR)
  • NRXP 0.16
  • TRSG 0.00
  • MACD
  • NRXP -0.07
  • TRSG 0.00
  • Stochastic Oscillator
  • NRXP 8.62
  • TRSG 0.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

Share on Social Networks: